What is Isomorphic Labs?
Isomorphic Labs is pioneering a new era in pharmaceutical research by reimagining the entire drug discovery process from first principles. Leveraging cutting-edge computational advances and an AI-first methodology, the company aims to model and understand fundamental biological mechanisms. This innovative approach is designed to dramatically increase the pace of scientific research and enhance the efficacy of new medicines, positioning Isomorphic Labs at the forefront of breakthroughs that could benefit millions globally. The company's strategic focus on digital biology and AI integration signals a significant shift in how therapeutic solutions are developed.
How much funding has Isomorphic Labs raised?
Isomorphic Labs has raised a total of $2.7B across 2 funding rounds:
Other Financing Round
$600M
Series B
$2.1B
Other Financing Round (2025): $600M with participation from Thrive Capital, Alphabet International, and GV
Series B (2026): $2.1B led by Thrive Capital, GV, Alphabet, Temasek, and CapitalG Management
Key Investors in Isomorphic Labs
Thrive Capital
Thrive Capital is an investment venture capital company based in New York, primarily focusing on internet and software investments.
GV
GV is a venture capital firm that invests across multiple stages and sectors, with a focus on enterprise solutions, life sciences, and frontier technology. They provide financial backing to promising startups and growth-stage businesses globally.
Alphabet International
Alphabet is a leading leasing company in Europe, Australia, and China, also pioneering advanced mobility solutions.
What's next for Isomorphic Labs?
With substantial backing and a clear strategic vision, Isomorphic Labs is poised for accelerated growth and innovation. The recent major strategic investment, coupled with its overall funding trajectory, indicates a strong market validation for its AI-driven drug discovery platform. This capital infusion will likely fuel further research and development, enabling the company to expand its computational capabilities and deepen its understanding of life sciences. Isomorphic Labs' commitment to leveraging AI for medical breakthroughs suggests a future focused on rapid pipeline advancement and the potential for significant contributions to global health.
See full Isomorphic Labs company page
